Patent classifications
A61K36/67
A Composition for Management of COVID-19 and Associated Disorders
The present disclosure provides a composition that may find utility in management of COVID-19. The inventors of the present disclosure surprisingly observed that ingredients of the composition of the present disclosure exhibit functional synergy therebetween, wherein the composition prevents virus replication and/or Virus entry into human cells, either wholly or in part, while modulating immune response of the patient. Hence, the composition of the present disclosure holds potential for wide spread usage in management of COVID-19, either alone or in combination with other preventive or palliative/symptomatic or therapeutic strategies.
A Composition for Management of COVID-19 and Associated Disorders
The present disclosure provides a composition that may find utility in management of COVID-19. The inventors of the present disclosure surprisingly observed that ingredients of the composition of the present disclosure exhibit functional synergy therebetween, wherein the composition prevents virus replication and/or Virus entry into human cells, either wholly or in part, while modulating immune response of the patient. Hence, the composition of the present disclosure holds potential for wide spread usage in management of COVID-19, either alone or in combination with other preventive or palliative/symptomatic or therapeutic strategies.
A Composition for Management of COVID-19 and Associated Disorders
The present disclosure provides a composition that may find utility in management of COVID-19. The inventors of the present disclosure surprisingly observed that ingredients of the composition of the present disclosure exhibit functional synergy therebetween, wherein the composition prevents virus replication and/or Virus entry into human cells, either wholly or in part, while modulating immune response of the patient. Hence, the composition of the present disclosure holds potential for wide spread usage in management of COVID-19, either alone or in combination with other preventive or palliative/symptomatic or therapeutic strategies.
Oral compositions for bladder regulation and uses thereof
Oral compositions for supporting bladder function, reduce frequency of urination, and/or improve or maintain bladder control, suitable for oral administration, are described. Methods of use and uses are described, which include the step of administering an effective amount of the oral compositions to supporting bladder function, reduce frequency of urination, and/or improve or maintain bladder control.
Oral compositions for bladder regulation and uses thereof
Oral compositions for supporting bladder function, reduce frequency of urination, and/or improve or maintain bladder control, suitable for oral administration, are described. Methods of use and uses are described, which include the step of administering an effective amount of the oral compositions to supporting bladder function, reduce frequency of urination, and/or improve or maintain bladder control.
Oral compositions for bladder regulation and uses thereof
Oral compositions for supporting bladder function, reduce frequency of urination, and/or improve or maintain bladder control, suitable for oral administration, are described. Methods of use and uses are described, which include the step of administering an effective amount of the oral compositions to supporting bladder function, reduce frequency of urination, and/or improve or maintain bladder control.
COMPOSITIONS COMPRISING FUNCTIONAL FRAGRANCES AND CANNABIS-DERIVED COMPOUNDS
The present technology generally relates to compositions comprising at least one purified cannabinoid or a derivative thereof, and at least one functional fragrance. The present technology also generally relates to methods of using the compositions for, inter alia, improving sleep, for treating insomnia and/or related sleep disorders.
COMPOSITIONS COMPRISING FUNCTIONAL FRAGRANCES AND CANNABIS-DERIVED COMPOUNDS
The present technology generally relates to compositions comprising at least one purified cannabinoid or a derivative thereof, and at least one functional fragrance. The present technology also generally relates to methods of using the compositions for, inter alia, improving sleep, for treating insomnia and/or related sleep disorders.
COMPOSITIONS COMPRISING FUNCTIONAL FRAGRANCES AND CANNABIS-DERIVED COMPOUNDS
The present technology generally relates to compositions comprising at least one purified cannabinoid or a derivative thereof, and at least one functional fragrance. The present technology also generally relates to methods of using the compositions for, inter alia, improving sleep, for treating insomnia and/or related sleep disorders.
ORGANIC PAIN RELIEF AND HAIR GROWTH COMPOSITION
A natural supplement is described herein. The supplement includes a therapeutically effective amount of a composition. The composition includes: at least two materials having analgesic activity, at least two materials having anti-inflammatory activity, at least two materials having antioxidant activity, at least two materials having anti-neuralgic activity, at least two materials having blood circulation promotion activity, at least one material having Dihydrotestosterone (DHT) blocking activity, and at least one material having hair thickening activity or hair growth activity. The natural supplement not only provides pain relief from a variety of symptoms, but also promotes hair growth.